|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-5-7
|
|
pubmed:abstractText |
Ziprasidone and bupropion are medications prescribed for mood and behavior disorders. They have apparently safe cardiac safety profiles in both therapeutic and supratherapeutic doses, but recently the Federal Drug Administration has issued a caution regarding ziprasidone use in combination with other drugs that are known to prolong the QTc interval.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0731-3810
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
101-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12733844-Adolescent,
pubmed-meshheading:12733844-Anti-Arrhythmia Agents,
pubmed-meshheading:12733844-Antidepressive Agents, Second-Generation,
pubmed-meshheading:12733844-Antipsychotic Agents,
pubmed-meshheading:12733844-Bupropion,
pubmed-meshheading:12733844-Consciousness,
pubmed-meshheading:12733844-Depressive Disorder, Major,
pubmed-meshheading:12733844-Electrocardiography,
pubmed-meshheading:12733844-Heart Diseases,
pubmed-meshheading:12733844-Humans,
pubmed-meshheading:12733844-Hydrogen-Ion Concentration,
pubmed-meshheading:12733844-Lidocaine,
pubmed-meshheading:12733844-Long QT Syndrome,
pubmed-meshheading:12733844-Male,
pubmed-meshheading:12733844-Overdose,
pubmed-meshheading:12733844-Piperazines,
pubmed-meshheading:12733844-Suicide, Attempted,
pubmed-meshheading:12733844-Thiazoles
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
|
|
pubmed:affiliation |
Pediatric Critical Care Medicine, Naval Medical Center Portsmouth, Portsmouth, Virginia 23708, USA. akbiswas@mar.med.navy.mil
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
